Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001900959 | SCV002158715 | pathogenic | Maple syrup urine disease | 2021-08-31 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Val81*) in the DBT gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DBT are known to be pathogenic (PMID: 16579849, 16786533). This variant is not present in population databases (ExAC no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of maple syrup urine disease (PMID: 32812330). This variant is also known as c.241_242delGT. For these reasons, this variant has been classified as Pathogenic. |